Giuseppe Lippi: New Insights Into Antiphospholipid Antibodies and Cardiovascular Thrombosis
Giuseppe Lippi, Professor at University of Verona, Dean at Faculty of Medicine and Surgery, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am delighted to share our last collective article on ‘Antiphospholipid antibodies and cardiovascular thrombosis’ just published in Nature Reviews Cardiology.”
Title: Antiphospholipid antibodies and cardiovascular thrombosis
Authors: Sina Rashedi, Hannah Leyva, Saman A. Siddiqui, Syed Bukhari, Mariana B. Pfeferman, Nathan W. Watson, Francisco Ujueta, Mehrdad Zarghami, Bassil Bacare, Yogendra Kanthi, David Jimenez, Manuel Monreal, Deborah M. Siegal, Geoffrey D. Barnes, John W. Eikelboom, Michelle L. O’Donoghue, Christian T. Ruff, Mattia Galli, Brittany N. Weber, Samuel Z. Goldhaber, Sacha Uljon, Saskia Middeldorp, Renato D. Lopes, David A. Garcia, Gregory Y. H. Lip, Jeffery I. Weitz, Jean M. Connors, Harlan M. Krumholz, Jason S. Knight, Giuseppe Lippi, Mitchell S. V. Elkind, Mary Cushman, Karen H. Costenbader, Gregory Piazza, Behnood Bikdeli
Read the Full Article on Nature Reviews Cardiology
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 13, 2026, 16:51Ahmet Dirican: Apixaban vs Rivaroxaban in Acute VTE
-
Mar 13, 2026, 16:47Sinju Thomas: Combined Red Cell and Plasma Exchange for Severe FES in Sickle Cell Disease
-
Mar 13, 2026, 16:44Michael Makris: Lower Bleeding Risk With Apixaban vs Rivaroxaban in Acute Venous Thrombosis
-
Mar 13, 2026, 16:36Muhammad Bilal: Principles and Clinical Uses of the Coombs Test
-
Mar 13, 2026, 16:27Nikhil Ganjoo: Early Detection of Rare Diseases Through Newborn Genome Sequencing
-
Mar 13, 2026, 16:18Tareq Abadl: Anemia of Inflammation – Hepcidin Regulation of Iron
-
Mar 13, 2026, 16:15New Evidence From the COBRRA Trial in Acute VTE – THANZ
-
Mar 13, 2026, 16:09Wolfgang Miesbach: Brussels Will Be the Perfect Stage for EAHAD 2027
-
Mar 13, 2026, 15:59Nicola Pozzi: A Brand-New Mechanism to Reduce Thrombosis Without Increasing Bleeding Risk